The state of New Mexico currently has 2 active clinical trials seeking participants for Pulmonary Fibrosis research studies. These trials are conducted in various cities, including Albuquerque, Santa Fe, Las Cruces and Farmington.
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Recruiting
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Gender:
All
Ages:
40 years and above
Trial Updated:
03/01/2024
Locations: University of New Mexico Health Sciences Center, Albuquerque, New Mexico
Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Recruiting
This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults with Idiopathic Pulmonary Fibrosis.
Gender:
All
Ages:
40 years and above
Trial Updated:
02/29/2024
Locations: University of New Mexico School of Medicine, Albuquerque, New Mexico
Conditions: Idiopathic Pulmonary Fibrosis